ADARx Pharmaceuticals, Inc. (ADRX) revenue by segment
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$14.16+1.34 (+10.45%)
Close on Nov 19, 2026Market cap $1.52BP/E –Yield –
See a number that looks wrong?